Skip to main content
. Author manuscript; available in PMC: 2014 May 14.
Published in final edited form as: Mol Carcinog. 2011 Oct 17;51(12):952–962. doi: 10.1002/mc.20866

Figure 4.

Figure 4

Effect of apigenin on histone H3 and H4 acetylation in human prostate cancer cells. A, Increase in acetylation of histone H3 Panel 1, PC-3 cells and Panel 2, 22Rv1 cells with 20 μM and 40μM doses of apigenin and 20 ng/ml HDAC inhibitor TSA exposed for 24 h. B, Increase in acetylation of histone H4 Panel 1, PC-3 cells and Panel 2, 22Rv1 cells with 20 μM and 40 μM doses of apigenin and 20 ng/ml HDAC inhibitor TSA after 24 h treatment. The details are provided in ‘materials and methods’.